Integumen's (LON:SKIN) Gerry Brandon speaks to Proactive London's Andrew Scott after announcing they've secured a new £3mln three-year loan facility that requires no loan repayments until next year. He says the initial drawdown of £1.5mln provides them with sufficient working capital for its COVID-19 AI product development as well as for the expansion of Labskin support services into the US and Asia.
Integumen's Gerry Brandon details new £3mln facility for Labskin and Covid-19 expansion
Quick facts: Integumen
Price: 2.69 GBX
Market Cap: £29.02 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...FOR OUR FULL DISCLAIMER CLICK HERE